Claes Glassell, who was the CEO of Cerus Corporation from January 2008 until April 2011, holds an MBA from the University of Pennsylvania. His career focuses on the pharmaceutical industry, where he has made significant impacts. Interestingly, Glassell's resignation in...
Claes Glassell, who was the CEO of Cerus Corporation from January 2008 until April 2011, holds an MBA from the University of Pennsylvania. His career focuses on the pharmaceutical industry, where he has made significant impacts. Interestingly, Glassell's resignation in 2011 came just after he received a targeted bonus based on company performance, showing that he was deeply involved in the company's strategy. During his tenure, Glassell was awarded a total compensation of over $1 million in 2010, which included a performance-based bonus that directly tied to corporate goals achieved. Despite resigning with no cash bonus for 2011, he still had stock options granted in previous years, demonstrating a commitment to long-term company success. He was noted for his insider trading activities, with stock sales peaking around $1.31 million in August 2020, reflecting a strong personal financial stake in Cerus. Glassell's career reflects a blend of leadership in pharmaceuticals and a focus on measurable performance, which is critical in the fast-paced biotech world.